Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-16-569467
Filing Date
2016-04-29
Accepted
2016-04-29 16:31:01
Documents
6
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d187224d10ka.htm 10-K/A 359901
2 EX-10.28 d187224dex1028.htm EX-10.28 61724
3 EX-10.29 d187224dex1029.htm EX-10.29 58650
4 EX-31.1 d187224dex311.htm EX-31.1 8617
5 EX-31.2 d187224dex312.htm EX-31.2 8793
6 EX-32.1 d187224dex321.htm EX-32.1 5048
  Complete submission text file 0001193125-16-569467.txt   503837
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36150 | Film No.: 161607095
SIC: 8731 Services-Commercial Physical & Biological Research